Annual FCF
-$95.69 M
+$5.30 M+5.24%
31 December 2023
Summary:
Solid Biosciences annual free cash flow is currently -$95.69 million, with the most recent change of +$5.30 million (+5.24%) on 31 December 2023. During the last 3 years, it has fallen by -$16.65 million (-21.06%). SLDB annual FCF is now -2176.28% below its all-time high of -$4.20 million, reached on 31 December 2015.SLDB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$23.72 M
-$1.97 M-9.06%
30 September 2024
Summary:
Solid Biosciences quarterly free cash flow is currently -$23.72 million, with the most recent change of -$1.97 million (-9.06%) on 30 September 2024. Over the past year, it has dropped by -$2.81 million (-13.44%). SLDB quarterly FCF is now -2002.41% below its all-time high of $1.25 million, reached on 31 December 2020.SLDB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$91.73 M
-$5.44 M-6.31%
30 September 2024
Summary:
Solid Biosciences TTM free cash flow is currently -$91.73 million, with the most recent change of -$5.44 million (-6.31%) on 30 September 2024. Over the past year, it has increased by +$3.96 million (+4.14%). SLDB TTM FCF is now -778.30% below its all-time high of -$10.44 million, reached on 31 March 2017.SLDB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLDB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -13.4% | +4.1% |
| 3 y3 years | -21.1% | -10.2% | -16.1% |
| 5 y5 years | +1.4% | -8.4% | +5.5% |
SLDB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -21.1% | +5.2% | -39.4% | +32.9% | -16.1% | +18.9% |
| 5 y | 5 years | -66.4% | +5.2% | -2002.4% | +32.9% | -87.4% | +18.9% |
| alltime | all time | -2176.3% | +5.2% | -2002.4% | +32.9% | -778.3% | +18.9% |
Solid Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.72 M(+9.1%) | -$91.73 M(+6.3%) |
| June 2024 | - | -$21.75 M(-14.2%) | -$86.29 M(-6.8%) |
| Mar 2024 | - | -$25.34 M(+21.2%) | -$92.53 M(-3.3%) |
| Dec 2023 | -$95.69 M(-5.2%) | -$20.91 M(+14.4%) | -$95.69 M(-13.1%) |
| Sept 2023 | - | -$18.28 M(-34.7%) | -$110.12 M(-2.6%) |
| June 2023 | - | -$28.00 M(-1.8%) | -$113.11 M(+10.8%) |
| Mar 2023 | - | -$28.50 M(-19.3%) | -$102.12 M(+1.1%) |
| Dec 2022 | -$100.99 M(+27.8%) | -$35.34 M(+66.1%) | -$100.99 M(+15.8%) |
| Sept 2022 | - | -$21.27 M(+25.0%) | -$87.19 M(+3.1%) |
| June 2022 | - | -$17.01 M(-37.8%) | -$84.58 M(-0.5%) |
| Mar 2022 | - | -$27.37 M(+27.1%) | -$85.02 M(+7.6%) |
| Dec 2021 | -$79.05 M(+37.5%) | -$21.53 M(+15.4%) | -$79.05 M(+40.5%) |
| Sept 2021 | - | -$18.66 M(+6.9%) | -$56.26 M(+5.7%) |
| June 2021 | - | -$17.45 M(-18.5%) | -$53.25 M(+8.8%) |
| Mar 2021 | - | -$21.40 M(-1816.2%) | -$48.94 M(-14.9%) |
| Dec 2020 | -$57.50 M | $1.25 M(-108.0%) | -$57.50 M(-28.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$15.64 M(+19.0%) | -$80.64 M(-5.0%) |
| June 2020 | - | -$13.15 M(-56.1%) | -$84.88 M(-14.4%) |
| Mar 2020 | - | -$29.95 M(+36.8%) | -$99.18 M(+2.1%) |
| Dec 2019 | -$97.10 M(+24.5%) | -$21.89 M(+10.0%) | -$97.10 M(-1.0%) |
| Sept 2019 | - | -$19.89 M(-27.5%) | -$98.05 M(+2.6%) |
| June 2019 | - | -$27.44 M(-1.6%) | -$95.57 M(+9.0%) |
| Mar 2019 | - | -$27.88 M(+22.1%) | -$87.68 M(+12.4%) |
| Dec 2018 | -$77.97 M(+71.4%) | -$22.84 M(+31.2%) | -$77.97 M(+12.3%) |
| Sept 2018 | - | -$17.41 M(-10.9%) | -$69.44 M(+10.0%) |
| June 2018 | - | -$19.55 M(+7.6%) | -$63.13 M(+18.6%) |
| Mar 2018 | - | -$18.17 M(+27.0%) | -$53.23 M(+17.0%) |
| Dec 2017 | -$45.50 M(+121.8%) | -$14.31 M(+28.9%) | -$45.50 M(+45.9%) |
| Sept 2017 | - | -$11.10 M(+15.1%) | -$31.19 M(+55.3%) |
| June 2017 | - | -$9.65 M(-7.6%) | -$20.09 M(+92.4%) |
| Mar 2017 | - | -$10.44 M | -$10.44 M |
| Dec 2016 | -$20.51 M(+387.9%) | - | - |
| Dec 2015 | -$4.20 M | - | - |
FAQ
- What is Solid Biosciences annual free cash flow?
- What is the all time high annual FCF for Solid Biosciences?
- What is Solid Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Solid Biosciences?
- What is Solid Biosciences quarterly FCF year-on-year change?
- What is Solid Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Solid Biosciences?
- What is Solid Biosciences TTM FCF year-on-year change?
What is Solid Biosciences annual free cash flow?
The current annual FCF of SLDB is -$95.69 M
What is the all time high annual FCF for Solid Biosciences?
Solid Biosciences all-time high annual free cash flow is -$4.20 M
What is Solid Biosciences quarterly free cash flow?
The current quarterly FCF of SLDB is -$23.72 M
What is the all time high quarterly FCF for Solid Biosciences?
Solid Biosciences all-time high quarterly free cash flow is $1.25 M
What is Solid Biosciences quarterly FCF year-on-year change?
Over the past year, SLDB quarterly free cash flow has changed by -$2.81 M (-13.44%)
What is Solid Biosciences TTM free cash flow?
The current TTM FCF of SLDB is -$91.73 M
What is the all time high TTM FCF for Solid Biosciences?
Solid Biosciences all-time high TTM free cash flow is -$10.44 M
What is Solid Biosciences TTM FCF year-on-year change?
Over the past year, SLDB TTM free cash flow has changed by +$3.96 M (+4.14%)